Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Murine neuroblastoma cell lines developed by conditional reprogramming preserve heterogeneous phenotypes observed in vivo.

Krawczyk E, Hong SH, Galli S, Trinh E, Wietlisbach L, Misiukiewicz SF, Tilan JU, Chen YS, Schlegel R, Kitlinska J.

Lab Invest. 2019 Aug 13. doi: 10.1038/s41374-019-0297-7. [Epub ahead of print]

PMID:
31409888
2.

Hip dislocations and concurrent injuries in motor vehicle collisions.

Cooper J, Tilan J, Rounds AD, Rosario S, Inaba K, Marecek GS.

Injury. 2018 Jul;49(7):1297-1301. doi: 10.1016/j.injury.2018.04.023. Epub 2018 Apr 27.

PMID:
29739656
3.

A student guide to proofreading and writing in science.

Hyatt JK, Bienenstock EJ, Tilan JU.

Adv Physiol Educ. 2017 Sep 1;41(3):324-331. doi: 10.1152/advan.00004.2017. Review.

4.

A Retrospective Analysis of Complications Associated With Bone Morphogenetic Protein 2 in Anterior Lumbar Interbody Fusion.

Hindoyan K, Tilan J, Buser Z, Cohen JR, Brodke DS, Youssef JA, Park JB, Yoon ST, Meisel HJ, Wang JC.

Global Spine J. 2017 Apr;7(2):148-153. doi: 10.1177/2192568217694010. Epub 2017 Apr 6.

5.

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis.

Hong SH, Tilan JU, Galli S, Acree R, Connors K, Mahajan A, Wietlisbach L, Polk T, Izycka-Swieszewska E, Lee YC, Cavalli LR, Rodriguez OC, Albanese C, Kitlinska JB.

J Vis Exp. 2016 Dec 9;(118). doi: 10.3791/54532.

6.

Return of motor evoked potentials after knee flexion in the setting of high-grade spondylolisthesis.

Tilan J, Andras LM, Krieger MD, Skaggs DL.

Eur Spine J. 2017 Mar;26(3):619-622. doi: 10.1007/s00586-016-4853-1. Epub 2016 Nov 17.

PMID:
27858240
7.

Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma.

Galli S, Naranjo A, Van Ryn C, Tilan JU, Trinh E, Yang C, Tsuei J, Hong SH, Wang H, Izycka-Swieszewska E, Lee YC, Rodriguez OC, Albanese C, Kitlinska J.

Am J Pathol. 2016 Nov;186(11):3040-3053. doi: 10.1016/j.ajpath.2016.07.019. Epub 2016 Oct 12.

8.

Neuropeptide Y (NPY) in tumor growth and progression: Lessons learned from pediatric oncology.

Tilan J, Kitlinska J.

Neuropeptides. 2016 Feb;55:55-66. doi: 10.1016/j.npep.2015.10.005. Epub 2015 Oct 26. Review.

9.

Elevated levels of neuropeptide Y in preeclampsia: A pilot study implicating a role for stress in pathogenesis of the disease.

Paiva SP, Veloso CA, Campos FF, Carneiro MM, Tilan JU, Wang H, Umans JG, Zukowska Z, Kitlinska J.

Neuropeptides. 2016 Feb;55:127-35. doi: 10.1016/j.npep.2015.09.006. Epub 2015 Sep 25.

10.

High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastases.

Hong SH, Tilan JU, Galli S, Izycka-Swieszewska E, Polk T, Horton M, Mahajan A, Christian D, Jenkins S, Acree R, Connors K, Ledo P, Lu C, Lee YC, Rodriguez O, Toretsky JA, Albanese C, Kitlinska J.

Oncotarget. 2015 Mar 30;6(9):7151-65.

11.

Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival.

Tilan JU, Krailo M, Barkauskas DA, Galli S, Mtaweh H, Long J, Wang H, Hawkins K, Lu C, Jeha D, Izycka-Swieszewska E, Lawlor ER, Toretsky JA, Kitlinska JB.

Cancer. 2015 Mar 1;121(5):697-707. doi: 10.1002/cncr.29090. Epub 2014 Nov 11.

12.

Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance.

Czarnecka M, Trinh E, Lu C, Kuan-Celarier A, Galli S, Hong SH, Tilan JU, Talisman N, Izycka-Swieszewska E, Tsuei J, Yang C, Martin S, Horton M, Christian D, Everhart L, Maheswaran I, Kitlinska J.

Oncogene. 2015 Jun 11;34(24):3131-43. doi: 10.1038/onc.2014.253. Epub 2014 Aug 18.

13.

Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects.

Tilan JU, Lu C, Galli S, Izycka-Swieszewska E, Earnest JP, Shabbir A, Everhart LM, Wang S, Martin S, Horton M, Mahajan A, Christian D, O'Neill A, Wang H, Zhuang T, Czarnecka M, Johnson MD, Toretsky JA, Kitlinska J.

Oncotarget. 2013 Dec;4(12):2487-501.

14.

The biomechanical effect of increased valgus on total knee arthroplasty: a cadaveric study.

Bryant BJ, Tilan JU, McGarry MH, Takenaka N, Kim WC, Lee TQ.

J Arthroplasty. 2014 Apr;29(4):722-6. doi: 10.1016/j.arth.2013.09.003. Epub 2013 Oct 9.

PMID:
24120050
15.

Platelet neuropeptide Y is critical for ischemic revascularization in mice.

Tilan JU, Everhart LM, Abe K, Kuo-Bonde L, Chalothorn D, Kitlinska J, Burnett MS, Epstein SE, Faber JE, Zukowska Z.

FASEB J. 2013 Jun;27(6):2244-55. doi: 10.1096/fj.12-213546. Epub 2013 Mar 1.

16.

A new murine model of stress-induced complex atherosclerotic lesions.

Najafi AH, Aghili N, Tilan JU, Andrews JA, Peng X, Lassance-Soares RM, Sood S, Alderman LO, Abe K, Li L, Kolodgie FD, Virmani R, Zukowska Z, Epstein SE, Burnett MS.

Dis Model Mech. 2013 Mar;6(2):323-31. doi: 10.1242/dmm.009977. Epub 2013 Jan 11.

17.

Biomechanical effect of latissimus dorsi tendon transfer for irreparable massive cuff tear.

Oh JH, Tilan J, Chen YJ, Chung KC, McGarry MH, Lee TQ.

J Shoulder Elbow Surg. 2013 Feb;22(2):150-7. doi: 10.1016/j.jse.2012.01.022. Epub 2012 May 3.

PMID:
22560227
18.

Acupuncture at ST36 prevents chronic stress-induced increases in neuropeptide Y in rat.

Eshkevari L, Egan R, Phillips D, Tilan J, Carney E, Azzam N, Amri H, Mulroney SE.

Exp Biol Med (Maywood). 2012 Jan;237(1):18-23. doi: 10.1258/ebm.2011.011224. Epub 2011 Dec 7.

PMID:
22156045
19.

Impact of fibroblast growth factor-binding protein-1 expression on angiogenesis and wound healing.

Tassi E, McDonnell K, Gibby KA, Tilan JU, Kim SE, Kodack DP, Schmidt MO, Sharif GM, Wilcox CS, Welch WJ, Gallicano GI, Johnson MD, Riegel AT, Wellstein A.

Am J Pathol. 2011 Nov;179(5):2220-32. doi: 10.1016/j.ajpath.2011.07.043. Epub 2011 Sep 21.

20.

Dipeptidyl peptidases as survival factors in Ewing sarcoma family of tumors: implications for tumor biology and therapy.

Lu C, Tilan JU, Everhart L, Czarnecka M, Soldin SJ, Mendu DR, Jeha D, Hanafy J, Lee CK, Sun J, Izycka-Swieszewska E, Toretsky JA, Kitlinska J.

J Biol Chem. 2011 Aug 5;286(31):27494-505. doi: 10.1074/jbc.M111.224089. Epub 2011 Jun 16.

21.

Effects of aging on time course of neovascularization-related gene expression following acute hindlimb ischemia in mice.

Wang JS, Liu X, Xue ZY, Alderman L, Tilan JU, Adenika R, Epstein SE, Burnett MS.

Chin Med J (Engl). 2011 Apr;124(7):1075-81.

PMID:
21542971
22.

Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy.

Lu C, Everhart L, Tilan J, Kuo L, Sun CC, Munivenkatappa RB, Jönsson-Rylander AC, Sun J, Kuan-Celarier A, Li L, Abe K, Zukowska Z, Toretsky JA, Kitlinska J.

Oncogene. 2010 Oct 14;29(41):5630-42. doi: 10.1038/onc.2010.301. Epub 2010 Aug 2.

23.

Sympathetic Neurotransmitters and Tumor Angiogenesis-Link between Stress and Cancer Progression.

Tilan J, Kitlinska J.

J Oncol. 2010;2010:539706. doi: 10.1155/2010/539706. Epub 2010 May 20.

24.

Metallothionein enhances angiogenesis and arteriogenesis by modulating smooth muscle cell and macrophage function.

Zbinden S, Wang J, Adenika R, Schmidt M, Tilan JU, Najafi AH, Peng X, Lassance-Soares RM, Iantorno M, Morsli H, Gercenshtein L, Jang GJ, Epstein SE, Burnett MS.

Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):477-82. doi: 10.1161/ATVBAHA.109.200949. Epub 2010 Jan 7.

PMID:
20056912
25.

Chronic stress, combined with a high-fat/high-sugar diet, shifts sympathetic signaling toward neuropeptide Y and leads to obesity and the metabolic syndrome.

Kuo LE, Czarnecka M, Kitlinska JB, Tilan JU, Kvetnansk√Ĺ R, Zukowska Z.

Ann N Y Acad Sci. 2008 Dec;1148:232-7. doi: 10.1196/annals.1410.035.

26.

NPY and NPY receptors in vascular remodeling.

Abe K, Tilan JU, Zukowska Z.

Curr Top Med Chem. 2007;7(17):1704-9. Review.

PMID:
17979779
27.

Renal and cardiac neuropeptide Y and NPY receptors in a rat model of congestive heart failure.

Callanan EY, Lee EW, Tilan JU, Winaver J, Haramati A, Mulroney SE, Zukowska Z.

Am J Physiol Renal Physiol. 2007 Dec;293(6):F1811-7. Epub 2007 Sep 5.

28.

Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome.

Kuo LE, Kitlinska JB, Tilan JU, Li L, Baker SB, Johnson MD, Lee EW, Burnett MS, Fricke ST, Kvetnansky R, Herzog H, Zukowska Z.

Nat Med. 2007 Jul;13(7):803-11. Epub 2007 Jul 1. Erratum in: Nat Med. 2007 Sep;13(9):1120.

PMID:
17603492
29.

Role of neuropeptide Y and dipeptidyl peptidase IV in regulation of Ewing's sarcoma growth.

Kitlinska J, Kuo L, Abe K, Pons J, Yu M, Li L, Tilan J, Toretsky J, Zukowska Z.

Adv Exp Med Biol. 2006;575:223-9. Review. No abstract available.

PMID:
16700526
30.

Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors.

Kitlinska J, Abe K, Kuo L, Pons J, Yu M, Li L, Tilan J, Everhart L, Lee EW, Zukowska Z, Toretsky JA.

Cancer Res. 2005 Mar 1;65(5):1719-28.

31.

Retinoids and pulmonary hypertension.

Preston IR, Tang G, Tilan JU, Hill NS, Suzuki YJ.

Circulation. 2005 Feb 15;111(6):782-90. Epub 2005 Feb 7.

PMID:
15699255
32.

Cationic polypeptides are required for antibacterial activity of human airway fluid.

Cole AM, Liao HI, Stuchlik O, Tilan J, Pohl J, Ganz T.

J Immunol. 2002 Dec 15;169(12):6985-91.

Supplemental Content

Support Center